In addition, overexpression of miR-1-3p in naïve CD4 + T cells could promote Th17 cell differentiation by increasing the levels of inflammatory mediators; thus, knockout of miR-1-3p may be a potential therapeutic strategy for MS (Li et al., 2020). The gene discussed is CD4; the disease is myeloid sarcoma.